Mitochondrial double-stranded RNA triggers induction of the antiviral DNA deaminase APOBEC3A and nuclear DNA damage.
APOBEC3A
DNA damage response
cancer mutagenesis
innate immune signaling
mitochondrial dsRNA
Journal
The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R
Informations de publication
Date de publication:
09 2023
09 2023
Historique:
received:
08
05
2023
revised:
27
06
2023
accepted:
28
06
2023
medline:
10
11
2023
pubmed:
21
7
2023
entrez:
20
7
2023
Statut:
ppublish
Résumé
APOBEC3A is an antiviral DNA deaminase often induced by virus infection. APOBEC3A is also a source of cancer mutation in viral and nonviral tumor types. It is therefore critical to identify factors responsible for APOBEC3A upregulation. Here, we test the hypothesis that leaked mitochondrial (mt) double-stranded (ds)RNA is recognized as foreign nucleic acid, which triggers innate immune signaling, APOBEC3A upregulation, and DNA damage. Knockdown of an enzyme responsible for degrading mtdsRNA, the exoribonuclease polynucleotide phosphorylase, results in mtdsRNA leakage into the cytosol and induction of APOBEC3A expression. APOBEC3A upregulation by cytoplasmic mtdsRNA requires RIG-I, MAVS, and STAT2 and is likely part of a broader type I interferon response. Importantly, although mtdsRNA-induced APOBEC3A appears cytoplasmic by subcellular fractionation experiments, its induction triggers an overt DNA damage response characterized by elevated nuclear γ-H2AX staining. Thus, mtdsRNA dysregulation may induce APOBEC3A and contribute to observed genomic instability and mutation signatures in cancer.
Identifiants
pubmed: 37474103
pii: S0021-9258(23)02101-4
doi: 10.1016/j.jbc.2023.105073
pmc: PMC10457583
pii:
doi:
Substances chimiques
APOBEC3A protein, human
EC 3.5.4.5
DNA
9007-49-2
RNA, Double-Stranded
0
RNA, Mitochondrial
0
Cytidine Deaminase
EC 3.5.4.5
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
105073Subventions
Organisme : NIAID NIH HHS
ID : R37 AI064046
Pays : United States
Organisme : NCI NIH HHS
ID : R37 CA252081
Pays : United States
Organisme : NCI NIH HHS
ID : P01 CA234228
Pays : United States
Organisme : NIAID NIH HHS
ID : R37 AI064046
Pays : United States
Organisme : NIAID NIH HHS
ID : F32 AI147813
Pays : United States
Informations de copyright
Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflict of interest The authors declare that they have no conflicts of interest with the contents of this article.